Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
September 30, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 7, 2025 - SVRA
September 30, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
SVRA
Exposures
Financial
Legal
Product Safety
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 7, 2025 - SVRA
September 30, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
SVRA
Exposures
Financial
Legal
Product Safety
Morgan Stanley Boosts Celsius Holdings (CELH) to Overweight: A Deep Dive into Growth Prospects and Market Implications
September 30, 2025
Via
MarketMinute
Topics
Economy
World Trade
Tickers
AMZN
CELH
MNST
MS
PEP
Exposures
Product Safety
Supply Chain
Tariff
Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery
September 29, 2025
Via
Stocktwits
Tickers
AUPH
Exposures
Product Safety
IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine
September 29, 2025
Via
Stocktwits
Tickers
IOBT
MRK
Exposures
Product Safety
FDA Guidance Sets Lantern Pharma Inc. (NASDAQ: LTRN) On a Path Toward Realizing Its Clinical Trial Plans for Rare Pediatric Cancer Therapy
September 30, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Tickers
LTRN
Exposures
Artificial Intelligence
Product Safety
Wall Street Defies D.C. Drama: Strong Gains Persist Amidst Looming Government Shutdown
September 30, 2025
Via
MarketMinute
Topics
Economy
Regulatory Compliance
Stocks
Tickers
AAPL
JNJ
LMT
MSFT
PFE
QQQ
Exposures
Economy
Interest Rates
Legal
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances TNX-2900 for Prader-Willi Syndrome Into Phase 2 Trial
September 30, 2025
Via
Investor Brand Network
Tickers
TNXP
Exposures
Product Safety
US Government Shutdown Looms: Market Braces for Impact on S&P 500, Dow, and Nasdaq
September 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Tickers
ABX
GOLD
LMT
MDT
NEE
NOC
Exposures
Artificial Intelligence
Economy
Interest Rates
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
September 30, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
UNCY
Exposures
Financial
Legal
Product Safety
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
September 30, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
UNCY
Exposures
Financial
Legal
Product Safety
OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update
September 30, 2025
Via
Newsfile
Tickers
OSTX
Exposures
Product Safety
Dollar Dips as Government Shutdown Looms: A Volatile Start to Q4 2025
September 29, 2025
Via
MarketMinute
Topics
Bonds
Economy
Government
Tickers
AAPL
BAH
DAL
JNJ
JPM
LMT
Exposures
Debt Markets
Economy
Interest Rates
Global Markets Brace for Impact as US Government Shutdown Looms
September 29, 2025
Via
MarketMinute
Topics
Bonds
Economy
Workforce
Tickers
ABX
BAC
GOLD
JPM
LMT
MRNA
Exposures
Debt Markets
Economy
Interest Rates
Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes
September 29, 2025
Via
MarketMinute
Tickers
BMY
GILD
GMAB
INCY
LLY
MRK
Exposures
Product Safety
NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST
September 29, 2025
Via
TheNewswire.com
Topics
Artificial Intelligence
Tickers
NMTC
Exposures
Artificial Intelligence
Product Safety
NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST
September 29, 2025
Via
NewMediaWire
Topics
Artificial Intelligence
Tickers
NMTC
Exposures
Artificial Intelligence
Product Safety
$750 Million Market Projected to Reach $3.35 Billion; Huge Opportunity for Superior Preservative-Free Ketamine Drug Treating Suicidal Depression $NRXP
September 29, 2025
Via
PRLog
Exposures
Product Safety
$750 Million Market Projected to Reach $3.35 Billion in 2034; Mega Opportunity for Superior Preservative-Free Ketamine Drug Treating Suicidal Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
September 29, 2025
Via
Get News
Tickers
NRXP
Exposures
Product Safety
New Teletherapy Program From Moment of Clarity Enhances Access to Mental Health Treatment
September 29, 2025
Via
Press Advantage
Exposures
Product Safety
AI Reshapes Healthcare: A Deep Dive into Innovation, Regulation, and Market Impact
September 29, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Fraud
Tickers
CTSH
MDRX
ORCL
UNH
Exposures
Artificial Intelligence
Legal
Product Safety
Ian Chait Brings Four Decades of Experience to Real Estate Leadership in Arizona
September 29, 2025
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
The Digital Pulse: Nursing Informatics and CNIOs Steer Healthcare's Digital Revolution
September 29, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Tickers
AMWL
ORCL
TDOC
Exposures
Artificial Intelligence
COVID-19
Product Safety
Why Guardant Health (GH) Stock Is Trading Up Today
September 29, 2025
Via
StockStory
Tickers
GH
JPM
LLY
WFC
Exposures
Product Safety
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM)
September 29, 2025
Via
Investor Brand Network
Tickers
NRXP
Exposures
Product Safety
Dow Futures Defy Shutdown Fears: A Deep Dive into Market Resilience
September 29, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Tickers
ABX
BA
BAH
BIIB
DAL
GOLD
Exposures
Artificial Intelligence
Economy
Interest Rates
Nasus Pharma Receives $22 Price Target and Buy Rating From Laidlaw & Company
September 29, 2025
Via
AB Newswire
Tickers
NSRX
Exposures
COVID-19
Product Safety
Palantir Technologies: Decoding the Data Giant’s AI Ambitions and Geopolitical Influence
September 29, 2025
Via
PredictStreet
Topics
Artificial Intelligence
Earnings
Fraud
Tickers
BA
JPM
PLTR
PYPL
RACE
Exposures
Artificial Intelligence
Financial
Legal
U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears
September 29, 2025
Via
MarketMinute
Topics
Bonds
Economy
Government
Tickers
AAL
ABX
AEP
BAC
D
DAL
Exposures
Debt Markets
Economy
Immigration
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.